AI Article Synopsis
- - The introduction of new therapies has significantly changed how multiple myeloma is treated, leading to improved outcomes.
- - Tailoring treatment based on patient characteristics and optimizing the sequence of drug use has reduced side effects and enhanced patients' survival and quality of life.
- - The Portuguese Multiple Myeloma Group offers evidence-based recommendations for both initial treatment and dealing with relapses, aiming to improve treatment standards in Portugal.
Article Abstract
The treatment of multiple myeloma has profoundly changed with the introduction of several innovative therapies. The optimization of therapeutic sequencing through the combined use of the various drugs developed in recent years and the attention given to the characteristics of patients have allowed the reduction of toxicities and increased survival and quality of life of patients with multiple myeloma. These treatment recommendations from the Portuguese Multiple Myeloma Group offer guidance for first-line treatment and progression/relapse situations. These recommendations are given highlighting the data that justify each choice and referring to the respective levels of evidence that support these options. Whenever possible, the respective national regulatory framework is presented. These recommendations constitute an advance towards the best treatment of multiple myeloma in Portugal.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.20344/amp.19037 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!